Follow-The-Filings

ACTU Actuate Therapeutics

Actuate Therapeutics earnings company data as of 7:03 AM ET 8/20

History

1 period · newest first · EPS & Rev stacked

Period Date Metric Estimate Actual Result
FY2026 Q2 14 Aug EPS -0.20
Rev

SEC filings

Recent issuer filings from EDGAR · 23 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
10-Q FORM 10-Q FOR JUN 2026
8-K 3.01
8-K 5.07
10-Q FORM 10-Q FOR MAR 2026
8-K 7.01,9.01
8-K 5.02,8.01,9.01
DEFA14A ADDITIONAL DEFINITIVE PROXY SOLICITING MATERIALS
DEFA14A DEFA14A
10-K FORM 10-K FOR DEC 2025
8-K 7.01,9.01
424B5 SUPPLEMENT TO PROSPECTUS DATED 9-8-25
8-K 1.01,9.01
8-K 8.01
10-Q FORM 10-Q FOR SEP 2025
424B5 PROSPECTUS
8-K 1.01,8.01,9.01
424B5 424B5
10-Q FORM 10-Q FOR JUN 2025
424B3 FORM 424B3
S-1 REGISTRATION STATEMENT
8-K 1.01,3.02,9.01
8-K 7.01,9.01
8-K 7.01,8.01,9.01

Insider forms

Form 3 / 4 / 5 from EDGAR · 5 of 17 shown

Filed Form Detail Links
4 Period Aug 14, 2026
4 Period May 21, 2026
4 Period May 21, 2026
4 Period May 21, 2026
4 Period May 21, 2026

12 more insider forms →

Consensus estimates · SEC filings remain the official record · not investment advice